Cost-Effectiveness of Smoking Cessation Approaches in Emergency Departments

被引:2
|
作者
Miller, Ted R. [1 ,2 ,12 ]
Johnson, Mark B. [1 ,2 ]
Dziura, James D. [3 ]
Weiss, June [3 ]
Carpenter, Kelly M. [4 ]
Grau, Lauretta E. [5 ]
V. Pantalon, Michael [3 ]
Abroms, Lorien [6 ]
Collins, Linda M. [7 ]
Toll, Benjamin A. [8 ,9 ]
Bernstein, Steven L. [10 ,11 ]
机构
[1] Pacific Inst Res & Evaluat, Beltsville, MD USA
[2] Curtin Univ, Sch Publ Hlth, Perth, WA, Australia
[3] Yale Sch Med, Dept Emergency Med, New Haven, CT USA
[4] Optum Ctr Wellbeing Res, Seattle, WA USA
[5] Yale Sch Med, Yale Ctr Implementat Sci, New Haven, CT USA
[6] Washington Univ, Dept Prevent, Washington, DC USA
[7] NYU, Sch Global Publ Hlth, New Haven, CT USA
[8] Yale Canc Ctr, New Haven, CT USA
[9] Med Univ South Carolina, Charleston, SC USA
[10] Dartmouth Hitchcock Med Ctr, Lebanon, NH USA
[11] Dartmouth Geisel Sch Med, Hanover, NH USA
[12] Pacific Inst Res & Evaluat, 4061 Powder Mill Rd,Suite 350, Beltsville, MD 20705 USA
关键词
D O I
10.1016/j.amepre.2023.01.006
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: Americans of lower SES use tobacco products at disproportionately high rates and are over-represented as patients of emergency departments. Accordingly, emergency department visits are an ideal time to initiate tobacco treatment and aftercare for this vulnerable and understudied population. This research estimates the costs per quit of emergency department smokingcessation interventions and compares them with those of other approaches. Methods: Previously published research described the effectiveness of 2 multicomponent smoking line referral, and follow-up communication. Study 1 (collected in 2010-2012) only analyzed the combined interventions. Study 2 (collected in 2017-2019) analyzed the intervention components independently. Costs per participant and per quit were estimated separately, under distinct intervention with dedicated staff and intervention with repurposed staff assumptions. The distinction concerns whether the intervention used dedicated staff for delivery or whether time from existing staff was repurposed for intervention if available.Results: Data were analyzed in 2021-2022. In the first study, the cost per participant was $860 (2018 dollars), and the cost per quit was $11,814 (95% CI=$7,641, $25,423) (dedicated) and $227 per participant and $3,121 per quit (95% CI=$1,910, $7,012) (repurposed). In Study 2, the combined effect of brief negotiated interviewing, nicotine replacement therapy, and quitline cost $808 per participant and $6,100 per quit (dedicated) (95% CI=$4,043, $12,274) and $221 per participant and $1,669 per quit (95% CI=$1,052, $3,531) (repurposed).Conclusions: Costs varied considerably per method used but were comparable with those of other smoking cessation interventions. Am J Prev Med 2023;65(1):39-44.& COPY; 2023 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:39 / 44
页数:6
相关论文
共 50 条
  • [41] Cost-Effectiveness of a Health System-Based Smoking Cessation Program
    Levy, Douglas E.
    Klinger, Elissa V.
    Linder, Jeffrey A.
    Fleegler, Eric W.
    Rigotti, Nancy A.
    Park, Elyse R.
    Haas, Jennifer S.
    NICOTINE & TOBACCO RESEARCH, 2017, 19 (12) : 1508 - 1515
  • [42] Systematic review of economic evaluations of smoking cessation: Standardizing the cost-effectiveness
    Ronckers, ET
    Groot, W
    Ament, AJHA
    MEDICAL DECISION MAKING, 2005, 25 (04) : 437 - 448
  • [43] Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment
    D F Heitjan
    D A Asch
    Riju Ray
    Margaret Rukstalis
    Freda Patterson
    C Lerman
    The Pharmacogenomics Journal, 2008, 8 : 391 - 399
  • [44] Cost-effectiveness of point of care smoking cessation interventions in oncology clinics
    Mullen, Kerri A.
    Hurley, Kelly
    Hewitson, Shelley
    Scoville, Joshua
    Grant, Alyssa
    Thavorn, Kednapa
    Kumar, Eshwar
    Warren, Graham W.
    BRITISH JOURNAL OF CANCER, 2024, 131 (07) : 1178 - 1185
  • [45] Cost-effectiveness of a Smoking Cessation Intervention for Parents in Pediatric Primary Care
    Drouin, Olivier
    Sato, Ryoko
    Drehmer, Jeremy E.
    Nabi-Burza, Emara
    Hipple Walters, Bethany
    Winickoff, Jonathan P.
    Levy, Douglas E.
    JAMA NETWORK OPEN, 2021, 4 (04)
  • [46] Cost-effectiveness of a nurse-delivered, inpatient smoking cessation intervention
    Ward, Charlotte E.
    Hall, Stephanie, V
    Barnett, Paul G.
    Jordan, Neil
    Duffy, Sonia A.
    TRANSLATIONAL BEHAVIORAL MEDICINE, 2020, 10 (06) : 1481 - 1490
  • [47] A long term cost-effectiveness analysis model for smoking cessation in Mexico
    Mould-Quevedo, J.
    Saenz-Montanez, J.
    Davila-Loaiza, G.
    VALUE IN HEALTH, 2007, 10 (03) : A101 - A101
  • [48] Cost-effectiveness analysis of a family physician delivered smoking cessation program
    Buck, DJ
    Richmond, RL
    Mendelsohn, CP
    PREVENTIVE MEDICINE, 2000, 31 (06) : 641 - 648
  • [49] Cost-effectiveness analysis of Champix® (varenicline) in smoking cessation treatment in Spain
    F Bobadilla, J.
    Brosa, M.
    Wilson, K.
    Sánchez Maestre, C.
    VALUE IN HEALTH, 2007, 10 (06) : A471 - A472
  • [50] Cost-effectiveness of smoking cessation programs for hospitalized patients: a systematic review
    Donghoon Lee
    Ye-Rin Lee
    In-Hwan Oh
    The European Journal of Health Economics, 2019, 20 : 1409 - 1424